RecruitingNot ApplicableNCT07075159

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing


Sponsor

Janice Hernandez, MD

Enrollment

20 participants

Start Date

Feb 28, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to explore the use of a hydrocolloid dressing (DuoDERM EXTRA THIN) as an alternative to the current standard of care. The dressing would be applied immediately after surgery and removed at a post-operative week 1 appointment. The dressing would eliminate the need for antibiotic ointment application and reduce the burden of post-operative care on the patient.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria4

  • Patients \>18 years of age
  • follow-up at specified intervals (1 week/6 week/3 months) in an office setting
  • can give informed consent
  • no patients will be excluded on the basis of gender, ethnicity, or religious background

Exclusion Criteria4

  • Patients \<18 years of age or \>100
  • allergy to pectin, gelatin, and sodium carboxymethylcellulose
  • adults with impaired consent capacity
  • incarcerated individuals.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHydrocolloid Wound Dressing

one time hydrocolloid dressing application


Locations(1)

University of Kentucky

Lexington, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07075159


Related Trials